Skip to main content

Merton

Response to FOI (original text)

Your plans for meeting the NHS England Libre policy

In July 2018, FreeStyle Libre was approved for use in NHS Merton CCG. In developing this policy, the Regional Medicines Optimisation Committee (RMOC) - North statement was considered by NHS England London diabetes clinical networks (Clinical Leadership Group and Type 1 Diabetes Network). Additional advice was sought from members of the South East Coast and London and Young Peoples Diabetes Network for paediatric patients. These groups had representation from a variety of clinicians,commissioners and patient representatives.

On the 7th March 2019, NHS England published revised criteria for ‘Flash Glucose Monitoring: National Arrangement for Funding of Relevant Diabetes Patients’ publication’. NHS Merton CCG recognises that Flash Glucose Monitoring is a novel and innovative device and will now consider the recommendations in this document for the benefit of the patient group as specified.

How the Libre prescribing process will be handled? Will it be Red, Amber or Green listed?

NHS Merton CCG will seek guidance from NHS England London Diabetes Clinical Networks and NHSLondon Procurement Partnership (LPP) to ensure the new policy and implementation is adopted in a consistent manner to other CCGs in London. This will ensure equity of access for patients in NHS Merton CCG. The process of approval for this new policy will include involvement of local clinicians to facilitate implementation. In addition, we will follow our usual governance routes for getting policies approved by our local decision-making committees.

NHS Merton CCG does not operate a traffic light classification for medical devices or drugs. Once the policy is approved, clinicians will be able to prescribe the device in line with the approved policy.

Comments

Popular posts from this blog

4.0!

Took my levels this morning and they were at the magic 4.0mmol/l level (72 in US units)! Had a biscuit in celebration! Latest graph above. Seems less predictable than I thought, but at least I am now generally below 10 most of the time. I believe I am however in the 'Honeymoon Period'. This is the time when the body is still producing a little insulin and therefore your levels are easier to control. I don't think that it lasts long. A thick blanket of snow has fallen during the night. I was meant to be going to London today, but I think I'll give it a miss. My daughter (2) saw the snow and got very excited. She had not been out in snow before. We had an excellent half hour out the front of the house making tracks and getting cold! In my nice warm office now drinking a big mug of tea and looking at the snow continuing to fall. Won't be late home tonight.

Freestyle Liberating

So,what's all the fuss about? Today's graph with two Nutella-covered wraps - no Low Carb here! The Abbott Freestyle Libre is a paradigm-changing piece of medical equipment.  It has been warmly embraced by many of the diabetic community since its launch almost three years ago (its birthday is on 16th October).  So what's all the fuss about and is it justified? In my opinion, yes , but with some important caveats, especially with how you use it and interpret the results.  These are my tips for getting the most out of it: Use it for trends - stop thinking you need to compare it to other meters.  The only reason you should continue to test traditionally is to meet requirements of DVLA.  OK, if you are hypo-unaware, I can see logic in checking.  Yes, it can be 'inaccurate' but that's hard to quantify.  If you're far enough into your journey with diabetes, you should have a fair idea of what the scan is going to show.  If it doesn't match

Abbott dX 2022 Barcelona - "Make it Count"

For the past four years I've been invited by Abbott to a conference bringing together people with diabetes from across Europe to discuss various topics.  The first year I was meant to attend, it was my 'man v horse' year (the horse won!), so was unable to attend and then the pandemic hit so two further dX's were held virtually.  I was fortunate to be asked to present at last year's session.  This year's event was back in-person and held in Barcelona, coinciding with the latter part of the ATTD conference.   At this point, I must make it very clear - Abbott invited me to the 2022 European Diabetes Exchange forum (dX), that took place in Barcelona.  I attended this two-day event to connect and interact with inspirational and influential people in the diabetes community.  Abbott paid for my ticket and accommodation. #InvitedbyAbbott.  This is formal and it needs to be - I have not been required to do anything by Abbott as a result of my attendance and I hope that m